Paul Bycott
Impact in
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- Pulmonary and Respiratory Medicine top 0.2%
- Renal cell carcinoma treatment
- Lung Cancer Treatments and Mutations
Papers in
-
- Renal cell carcinoma treatment 19
- Lung Cancer Treatments and Mutations 11
- Oncology 20
- Pancreatic and Hepatic Oncology Research 8
- Colorectal Cancer Treatments and Studies 7
- Co-authors
- Olivier Rixe (7 shared papers)M. Dror Michaelson (4 shared papers)Robert J. Motzer (4 shared papers)Ronald M. Bukowski (2 shared papers)Thomas E. Hutson (2 shared papers)Sylvie Négrier (3 shared papers)Piotr Tomczak (1 shared paper)Stéphane Oudard (1 shared paper)
- Journals
- Journal of Clinical Oncology (15 papers)Annals of Oncology (3 papers)BMC Cancer (2 papers)The Lancet Oncology (2 papers)Statistics in Medicine (2 papers)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Paul Bycott
50 papers receiving 6.9k citations
Paul Bycott's Hit Papers
Peers
Comparison fields: 5 of 118
- Cancer Research 2.2k
- Pulmonary and Respiratory Medicine 4.5k
- Oncology 2.9k
- Molecular Biology 3.7k
- Endocrinology, Diabetes and Metabolism 518
Countries citing papers authored by Paul Bycott
This map shows the geographic impact of Paul Bycott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Bycott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Bycott more than expected).
Fields of papers citing papers by Paul Bycott
This network shows the impact of papers produced by Paul Bycott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Bycott. The network helps show where Paul Bycott may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Bycott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma Hit paper breakdown → | 2007 | 4471 |
| 2 | Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study Hit paper breakdown → | 2008 | 494 |
| 3 | 2007 | 356 | |
| 4 | 2011 | 322 | |
| 5 | 2008 | 204 | |
| 6 | 2009 | 146 | |
| 7 | 2003 | 106 | |
| 8 | 2014 | 86 | |
| 9 | 2011 | 84 | |
| 10 | 2005 | 71 | |
| 11 | 1998 | 62 | |
| 12 | 2007 | 62 | |
| 13 | 2014 | 47 | |
| 14 | 2008 | 44 | |
| 15 | 2014 | 42 | |
| 16 | 2011 | 39 | |
| 17 | 2005 | 38 | |
| 18 | 2013 | 36 | |
| 19 | 2007 | 35 | |
| 20 | 2021 | 33 |
About Paul Bycott
Paul Bycott is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Economics and Econometrics, having authored 51 papers that have together received 7.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (19 papers), Cancer Genomics and Diagnostics (17 papers), Lung Cancer Treatments and Mutations (11 papers), Pancreatic and Hepatic Oncology Research (8 papers), Colorectal Cancer Treatments and Studies (7 papers), Economic and Financial Impacts of Cancer (7 papers), Renal and related cancers (6 papers) and Statistical Methods in Clinical Trials (6 papers). The work is most often cited by research in Cancer Research (2.2k citations), Pulmonary and Respiratory Medicine (4.5k citations), Oncology (2.9k citations), Molecular Biology (3.7k citations) and Endocrinology, Diabetes and Metabolism (518 citations). Paul Bycott has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Olivier Rixe, M. Dror Michaelson, Robert J. Motzer, Ronald M. Bukowski, Thomas E. Hutson, Sylvie Négrier, Piotr Tomczak, Stéphane Oudard, Robert A. Figlin and Cezary Szczylik. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, BMC Cancer, The Lancet Oncology and Statistics in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.